International Biotechnology Trust plc is a UK-based investment trust, which invests in biotechnology and healthcare companies. The trust invests in the private equities, but a major proportion of its investments are made in the public markets. It was founded in the year 1994, and its headquarters are situated in London. The company is listed and traded on the main market of the London Stock Exchange publicly. The Alternative Investment Fund Manager of International Biotechnology Trust is SV Health Investors, which is a specialist healthcare fund manager.

The investment objective of the company is to create a diversified portfolio of high-quality assets which help in maximising the long-term risk adjusted income and capital returns for all its shareholders. The investments are made to cater to the medical needs in biotechnology and life sciences companies. The companies in the portfolio may be quoted or unquoted and may also belong to related sectors such as healthcare services and medical devices. The quoted portfolio consists of the investments made in listed companies, and accounts for a major proportion of the total assets. While the unquoted portfolio consists of the unlisted companies, which include venture capital funds, and funds that are managed by the members or the investment manager too. There is an upper limit of 15% at the time of investing in any individual company. There is also a 15% cap on investing in any individual close-ended quoted investment company.

The company’s portfolio is geographically diversified too, and covers small, mid and large-cap companies, which are mainly listed on the North American stock exchanges, as it has a large number of commercialised and established biotech and healthcare companies. The portfolio also consists of investments in the European, Australian, and Asian markets. The top quoted investments of the company include Horizon Therapeutics, Alexion, Vertex Pharmaceuticals, Regeneron, and PTC Therapeutics etc. The top unquoted investments include Karus Therapeutics, Autifony Therapeutics, EBR Systems etc., while SV Fund VI is its venture capital fund.

International Biotechnology Trust plc follows a well-defined framework of corporate governance and aligns itself with the UK Corporate Governance Code. The board of the company has set up separate committees for audit, nomination, and management engagement. It has an ethical code of conduct for running its business operations and promotes a culture of trust, transparency, and accountability. The trust complies with the transparency rules, the Disclosure Guidance, the Market Abuse Regulation, as well as the AIFM directive. Apart from fulfilling all its corporate responsibilities, the company also fulfils its environmental and social responsibilities, and believes in responsible investing. It complies with international best practices and guidelines to create a sustainable business.

Contact Information

company address International Biotechnology Trust 10 Harewood Avenue LONDON NW1 6AA United Kingdom GBR

company phone+44 (0) 20 7421 7070

company website

Similar Companies